November 26th, 2013
Christian Thomas Ruff, a coauthor of the ENGAGE AF-TIMI 48 trial of edoxaban versus warfarin in patients with atrial fibrillation, discusses the future of novel anticoagulants.
January 17th, 2013
Two experts discuss the evolving landscape of novel anticoagulants for patients with AF. Do you agree with their perspectives? What questions do you have? What has your experience taught you?
November 28th, 2011
Three experts weigh in on findings from the ATLAS ACS 2-TIMI 51 and ADOPT trials.